Aura Biosciences Stock Price on December 3, 2024
| AURA Stock | USD 8.45 0.19 2.30% |
If you're considering investing in Aura Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aura Biosciences stands at 8.45, as last reported on the 6th of January, with the highest price reaching 8.51 and the lowest price hitting 8.31 during the day. At this point, Aura Biosciences is somewhat reliable. Aura Biosciences secures Sharpe Ratio (or Efficiency) of 0.0167, which signifies that the company had a 0.0167% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aura Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Aura Biosciences' Downside Deviation of 2.64, mean deviation of 2.46, and Risk Adjusted Performance of 0.0154 to double-check if the risk estimate we provide is consistent with the expected return of 0.0583%.
At present, Aura Biosciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 619 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 34.6 M. . At present, Aura Biosciences' Price Book Value Ratio is projected to increase based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 1.47, whereas Price Earnings Ratio is forecasted to decline to (4.34). Aura Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Aura |
Sharpe Ratio = 0.0167
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | AURA | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.5 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Aura Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aura Biosciences by adding it to a well-diversified portfolio.
Related Headline
C4 Therapeutics Headline on 3rd of December 2024
ArrowMark Colorado Holdings LLC Has 7.52 Million Stake in C4... by thelincolnianonline.com
ArrowMark Colorado Holdings LLC boosted its holdings in C4 Therapeutics, Inc. by 6.0 percent in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,319,484 shares of the companys stock after purchasing an additional 75,126 shares during the quarter. ArrowMark
Aura Biosciences Valuation on December 3, 2024
It is possible to determine the worth of Aura Biosciences on a given historical date. On December 3, 2024 Aura was worth 9.1 at the beginning of the trading date compared to the closed value of 8.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aura Biosciences stock. Still, in general, we apply an absolute valuation method to find Aura Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aura Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aura Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 9.36 | 9.53 | 9.11 | 9.14 | 136,002 | |
12/03/2024 | 9.10 | 9.26 | 8.61 | 8.63 | 201,713 |
| 8.70 | 8.80 | 8.43 | 8.48 | 162,575 |
| Backtest Aura Biosciences | | | Aura Biosciences History | | | Aura Biosciences Valuation | Previous | Next |
Aura Biosciences Trading Date Momentum on December 3, 2024
| On December 04 2024 Aura Biosciences was traded for 8.48 at the closing time. The top price for the day was 8.80 and the lowest listed price was 8.43 . The trading volume for the day was 162.6 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.74% . The overall trading delta against the current closing price is 2.78% . |
Aura Biosciences Fundamentals Correlations and Trends
By evaluating Aura Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aura Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aura financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Aura Biosciences Stock history
Aura Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aura is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aura Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aura Biosciences stock prices may prove useful in developing a viable investing in Aura Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 45.6 M | 34.6 M | |
| Net Loss | -52.9 M | -55.5 M |
Aura Biosciences Quarterly Net Working Capital |
|
Aura Biosciences Stock Technical Analysis
Aura Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Aura Biosciences Period Price Range
Low | January 6, 2025
| High |
0.00 | 0.00 |
Aura Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Aura Biosciences January 6, 2025 Market Strength
Market strength indicators help investors to evaluate how Aura Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aura Biosciences shares will generate the highest return on investment. By undertsting and applying Aura Biosciences stock market strength indicators, traders can identify Aura Biosciences entry and exit signals to maximize returns
Aura Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aura Biosciences' price direction in advance. Along with the technical and fundamental analysis of Aura Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aura to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0154 | |||
| Jensen Alpha | 0.0204 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0039 | |||
| Treynor Ratio | 0.1215 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Aura Stock analysis
When running Aura Biosciences' price analysis, check to measure Aura Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aura Biosciences is operating at the current time. Most of Aura Biosciences' value examination focuses on studying past and present price action to predict the probability of Aura Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aura Biosciences' price. Additionally, you may evaluate how the addition of Aura Biosciences to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |